Fibralign Corporation

Fibralign Corporation is a Stanford University spin-out that produces advanced therapeutic biomedical devices, utilizing its powerful patented Nanoweave technology for creating 3D scaffolding which precisely mimics human tissue structure. This technology has been proven to directly influence desired cell behavior for repairing diseased tissue and can be further utilized as a bioreactor providing sustained localized delivering of cells and gene therapy for precisely targeting therapy. Fibralign has launched its first product the BioBridge Collagen Matrix for the treatment of secondary lymphedema, a global chronic and disfiguring disease that currently has no cure. Fibralign has been recognized for its innovation and...

Regenerative medicine,scaffolding technology,lymphedema,pad,nerve repair,medical device,drug delivery,muscle repair,iso 13485,collagen scaffolding,3d printing,breast cancer,wound care,and soft tissue

Fibralign corporation's HQ phone number is +1 415-902-4721

Fibralign corporation's revenue is 11m - 100m

Fibralign corporation has 11 - 50 employees.